Margaret Lotz
Overview
Explore the profile of Margaret Lotz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roy R, Man E, Aldakhlallah R, Gonzalez K, Merritt L, Daisy C, et al.
Biochim Biophys Acta Mol Basis Dis
. 2024 Jun;
1870(7):167325.
PMID: 38925485
The mechanism(s) underlying obesity-related postmenopausal (PM) breast cancer (BC) are not clearly understood. We hypothesized that the increased local presence of 'obese' mammary adipocytes within the BC microenvironment promotes the...
2.
Yue T, Wong L, Jani C, Agarwal L, Al Omari O, Aghagoli G, et al.
J Surg Res
. 2024 Jun;
PMID: 38862305
Introduction: Lung cancer is consistently the leading cause of cancer death among women in the United States, yet lung cancer screening (LCS) rates remain low. By contrast, screening mammography rates...
3.
Chrysafi P, Jani C, Lotz M, Al Omari O, Singh H, Stafford K, et al.
Cancers (Basel)
. 2023 Dec;
15(24).
PMID: 38136308
Hereditary Breast and Ovarian Cancer (HBOC) and Lynch Syndrome (LS) are the most common inherited cancer syndromes identified with genetic testing. Testing, though, commonly reveals variants of uncertain significance (VUSs)....
4.
Jani C, Lotz M, Keates S, Gupta Y, Walker A, Al Omari O, et al.
Breast J
. 2023 Apr;
2023:8185446.
PMID: 37114120
Lobular neoplasia (LN) involves proliferative changes within the breast lobules. LN is divided into lobular carcinoma in situ (LCIS) and atypical lobular hyperplasia (ALH). LCIS can be further subdivided into...
5.
Lotz M, Ghebremichael M, Chervinsky K, Zorc T, Brenner C, Bousvaros G, et al.
Clin Breast Cancer
. 2021 Aug;
22(3):e263-e269.
PMID: 34429241
Background: This study addresses the effectiveness of risk models and screening breast magnetic resonance imaging (MRI) in women who have atypical hyperplasia (AH), lobular carcinoma in situ (LCIS), or a...
6.
Minami C, Freedman R, Karamourtopoulos M, Pinheiro A, Gilliam E, Aliberti G, et al.
J Geriatr Oncol
. 2021 Mar;
12(5):724-730.
PMID: 33678596
Objectives: A comprehensive decision aid (DA) for women ≥70 years with Stage I ER+/HER2-negative breast cancer was developed to support locoregional and systemic treatment decision-making. We aimed to test the...
7.
Zarwan C, Diamond O, Lam P, Ghebremichael M, Lotz M, Shen A, et al.
Breast J
. 2020 Oct;
27(1):48-51.
PMID: 33099843
Atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS) are markers for an increased risk of breast cancer, yet outcomes for these diagnoses are not well-documented. In this study, all...
8.
Pories S, Myers L, Dusenbery K, Lotz M, Weissmann L
Breast J
. 2019 Apr;
25(3):560-561.
PMID: 30957343
No abstract available.
9.
Krikorian S, Pories S, Tataronis G, Caughey T, Chervinsky K, Lotz M, et al.
J Oncol Pharm Pract
. 2018 Sep;
25(7):1590-1598.
PMID: 30253725
Purpose: There is very little data on the effect of combining methods to better predict and improve oral antineoplastic adherence in cancer patients. The goal of this study was to...
10.
Lotz M, Wang H, Cance W, Matthews J, Pories S
J Surg Res
. 2003 Mar;
109(2):123-9.
PMID: 12643853
Background And Aims: Cancer progression is in large part dependent on the complex process of cell invasion, involving adhesion, motility, and enzymatic proteolysis. Overexpression of the Src proto-oncogene (c-Src), a...